HEMISPHERE ENERGY CORP (HME.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:HME - CA4236301020 - Common Stock
1.99 CAD
+0.04 (+2.05%)
We assign a fundamental rating of 7 out of 10 to HME. HME was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. HME scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HME has a bad growth rate and is valued cheaply. These ratings would make HME suitable for value investing!
1. Profitability
1.1 Basic Checks
- In the past year HME was profitable.
- In the past year HME had a positive cash flow from operations.
- HME had positive earnings in 4 of the past 5 years.
- In the past 5 years HME always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 24.66%, HME belongs to the top of the industry, outperforming 97.63% of the companies in the same industry.
- HME's Return On Equity of 38.33% is amongst the best of the industry. HME outperforms 99.05% of its industry peers.
- The Return On Invested Capital of HME (31.98%) is better than 100.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for HME is significantly above the industry average of 6.52%.
- The 3 year average ROIC (38.31%) for HME is well above the current ROIC(31.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROIC | 31.98% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
1.3 Margins
- Looking at the Profit Margin, with a value of 30.81%, HME belongs to the top of the industry, outperforming 94.79% of the companies in the same industry.
- In the last couple of years the Profit Margin of HME has grown nicely.
- HME's Operating Margin of 42.73% is amongst the best of the industry. HME outperforms 92.42% of its industry peers.
- HME's Operating Margin has improved in the last couple of years.
- With a decent Gross Margin value of 60.82%, HME is doing good in the industry, outperforming 78.67% of the companies in the same industry.
- In the last couple of years the Gross Margin of HME has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% |
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
2. Health
2.1 Basic Checks
- HME has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for HME has been reduced compared to 1 year ago.
- HME has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, HME has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 4.82 indicates that HME is not in any danger for bankruptcy at the moment.
- HME's Altman-Z score of 4.82 is amongst the best of the industry. HME outperforms 84.83% of its industry peers.
- The Debt to FCF ratio of HME is 0.07, which is an excellent value as it means it would take HME, only 0.07 years of fcf income to pay off all of its debts.
- HME has a better Debt to FCF ratio (0.07) than 95.73% of its industry peers.
- HME has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of HME (0.03) is better than 75.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Altman-Z | 4.82 |
ROIC/WACC4.06
WACC7.87%
2.3 Liquidity
- A Current Ratio of 1.41 indicates that HME should not have too much problems paying its short term obligations.
- HME's Current ratio of 1.41 is fine compared to the rest of the industry. HME outperforms 71.56% of its industry peers.
- HME has a Quick Ratio of 1.41. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
- HME's Quick ratio of 1.41 is fine compared to the rest of the industry. HME outperforms 73.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
- HME shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.09%.
- HME shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 80.04% yearly.
- Looking at the last year, HME shows a decrease in Revenue. The Revenue has decreased by -0.77% in the last year.
- HME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.97% yearly.
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
3.2 Future
- Based on estimates for the next years, HME will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.87% on average per year.
- The Revenue is expected to decrease by -7.01% on average over the next years.
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue Next Year-5.82%
Revenue Next 2Y-3.77%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 6.63, the valuation of HME can be described as very cheap.
- Compared to the rest of the industry, the Price/Earnings ratio of HME indicates a rather cheap valuation: HME is cheaper than 91.47% of the companies listed in the same industry.
- HME's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
- A Price/Forward Earnings ratio of 7.43 indicates a rather cheap valuation of HME.
- Based on the Price/Forward Earnings ratio, HME is valued cheaper than 83.89% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, HME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.63 | ||
| Fwd PE | 7.43 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HME is valued cheaply inside the industry as 92.42% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HME indicates a rather cheap valuation: HME is cheaper than 97.63% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.31 | ||
| EV/EBITDA | 3.11 |
4.3 Compensation for Growth
- HME has an outstanding profitability rating, which may justify a higher PE ratio.
- A cheap valuation may be justified as HME's earnings are expected to decrease with -9.18% in the coming years.
PEG (NY)N/A
PEG (5Y)0.08
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
5. Dividend
5.1 Amount
- HME has a Yearly Dividend Yield of 5.13%, which is a nice return.
- HME's Dividend Yield is a higher than the industry average which is at 2.71.
- HME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.13% |
5.2 History
- HME has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- HME pays out 60.59% of its income as dividend. This is not a sustainable payout ratio.
DP60.59%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
TSX-V:HME (1/13/2026, 7:00:00 PM)
1.99
+0.04 (+2.05%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-25 2025-11-25/bmo
Earnings (Next)04-15 2026-04-15/amc
Inst Owners0.71%
Inst Owner ChangeN/A
Ins Owners16.81%
Ins Owner ChangeN/A
Market Cap188.31M
Revenue(TTM)98.24M
Net Income(TTM)30.27M
Analysts84
Price Target2.47 (24.12%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.13% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP60.59%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.91%
Min EPS beat(2)-2.91%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-1.48%
Min EPS beat(4)-2.91%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.87%
EPS beat(12)5
Avg EPS beat(12)1.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.89%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-0.21%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)0.35%
Revenue beat(12)7
Avg Revenue beat(12)-0.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.63 | ||
| Fwd PE | 7.43 | ||
| P/S | 1.92 | ||
| P/FCF | 4.31 | ||
| P/OCF | 3.39 | ||
| P/B | 2.38 | ||
| P/tB | 2.38 | ||
| EV/EBITDA | 3.11 |
EPS(TTM)0.3
EY15.08%
EPS(NY)0.27
Fwd EY13.46%
FCF(TTM)0.46
FCFY23.2%
OCF(TTM)0.59
OCFY29.51%
SpS1.04
BVpS0.83
TBVpS0.83
PEG (NY)N/A
PEG (5Y)0.08
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROCE | 42.48% | ||
| ROIC | 31.98% | ||
| ROICexc | 43.34% | ||
| ROICexgc | 43.34% | ||
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% | ||
| FCFM | 44.47% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
ROICexc(3y)41.04%
ROICexc(5y)31.02%
ROICexgc(3y)41.04%
ROICexgc(5y)31.02%
ROCE(3y)50.88%
ROCE(5y)39%
ROICexgc growth 3Y12.92%
ROICexgc growth 5Y20.01%
ROICexc growth 3Y12.92%
ROICexc growth 5Y20.01%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 105.19% | ||
| Cap/Sales | 12.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 104.31% | ||
| Profit Quality | 144.34% | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 4.82 |
F-Score6
WACC7.87%
ROIC/WACC4.06
Cap/Depr(3y)210.69%
Cap/Depr(5y)187.35%
Cap/Sales(3y)20.24%
Cap/Sales(5y)19.51%
Profit Quality(3y)104.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
Revenue Next Year-5.82%
Revenue Next 2Y-3.77%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
EBIT growth 1Y-3.75%
EBIT growth 3Y35.09%
EBIT growth 5Y31.88%
EBIT Next Year34.08%
EBIT Next 3Y-0.98%
EBIT Next 5Y-5.77%
FCF growth 1Y130.83%
FCF growth 3Y57.01%
FCF growth 5YN/A
OCF growth 1Y39.86%
OCF growth 3Y36.33%
OCF growth 5Y34.82%
HEMISPHERE ENERGY CORP / HME.CA FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status for HME stock?
ChartMill assigns a valuation rating of 8 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
Can you provide the profitability details for HEMISPHERE ENERGY CORP?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
What is the financial health of HEMISPHERE ENERGY CORP (HME.CA) stock?
The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.
Can you provide the dividend sustainability for HME stock?
The dividend rating of HEMISPHERE ENERGY CORP (HME.CA) is 4 / 10 and the dividend payout ratio is 60.59%.